%0 Generic
%A Aix, S.
%A Novello, S.
%A Garon, E.
%A Nakagawa, K.
%A Nadal, E.
%A Moro-Sibilot, D.
%A Alonso Garcia, M.
%A Fabre, E.
%A Frimodt-Moller, B.
%A Zimmermann, A.
%A Visseren-Grul, C.
%A Reck, M.
%T RELAY EU/US Subset: Ramucirumab Plus Erlotinib Improves Progression-Free Survival in First-Line EGFR Mutation-Positive NSCLC
%D 2019
%@ 1556-0864
%U https://hdl.handle.net/10668/27251
%K EU/US subset
%K EGFR-mutation positive NSCLC
%K Ramucirumab
%~